SCARB1 and fatty liver disease: Furthermore, SR-B1 immunoreactivity increases and is mainly located in the plasma membrane of hepatocytes, cytoplasm, and the membrane of lipid droplets, with positive expressions associated with the severity of hepatic steatosis [66].